Decay-accelerating Factor Limits Hemorrhage-instigated Tissue Injury and Improves Resuscitation Clinical Parameters
Abstract
Complement is invariably activated during trauma and contributes to tissue injury. Recombinant human decay-accelerating factor (DAF), a complement regulatory protein that inhibits both classical and alternative pathways, improves survival and reduces tissue damage in animal models of tissue injury. The extent to which DAF may facilitate resuscitation in hemorrhaged large animals is not known. Male Yorkshire swine assigned to one of six groups were subjected to controlled, isobaric hemorrhage over 15 min to a target mean arterial pressure (MAP) of 35 mm Hg. Hypotension was maintained for 20 min followed by a bolus intravenous injection of DAF or vehicle followed by Hextend resuscitation. Animals were observed for 3 h after hypotensive Hextend resuscitation. Survival, blood chemistry, and physiological parameters were recorded. Additionally, tissue from lung, small intestine, liver, and kidney were subjected to histopathologic evaluation and tissue deposition of complement- ment proteins was determined by immunohistochemistry, dot-blot, and Western blot analyses.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 29, 2012
- Accession Number
- ADA615024
Entities
People
- Andrew P Cap
- Frank Lebeda
- George C. Tsokos
- Jessica L. Slack
- Jurandir J. Dalle Lucca
- Michael Dubick
- Michael J. Falabella
- Milomir O. Simovic
- Yansong Li
Organizations
- United States Army Institute of Surgical Research